PTX3 and breast cancer: Moreover, the detection of increased levels of “systemic” PTX3, like in the urines of BC patients [15], may be the result of the general inflamed milieu generated by and during tumor progression, thus masking the regulatory effect exerted by PTX3 produced by cancer cells.